1/13/12 Contest Update
When the Big Ball dropped to bring in the New Year investors, especially biotechies, weren’t yet ready to end the fun. So a fair-sized contingent continued to party on Wall Street, tossing dollars like confetti at stocks. And, despite some sobering up before the coming three-day weekend, for the first two weeks of 2012 trading, the Nasdaq Biotech Index gained 7.5%, while the Contest median gained 8.21% and the Nasdaq Composite Index gained 4.05%.
PGO’s portfolio, kickstarted by DNDN, is our Contest leader with a smashing 18.95% YTD gain. No. 2, DEWDIL’s portfolio, up 16.08% YTD, got its boost from ACHN and another DNDN-driven portfolio, from BIOFISH, took third place with 15.14% YTD gain.
At Friday's close, remarkably, all 38 Contest portfolios were in the black with 21 of the 38 beating the NBI.
Below is the Top Ten list. Also below are the Top 5 & Bottom 5 Stocks ranked by % Gained and % Lost for the week (foreign stock prices are not converted to US$ in these two tables).
Portfolio adjustments: None
Have a wonderful MLK birthday weekend biotechies!
(All corrections, especially adjustments for splits, greatly appreciated.)
1/13/12
Rank Name Profit/Loss
1 PGO 18,954
2 DEWDIL 16,082
3 BIOFISH 15,144
4 BIOMAV 14,055
5 CLARK 13,401
6 DOUGH 13,285
7 TUCK 12,562
8 BIOJIM 12,179
9 ARTHUR 11,926
10 RKRW 10,528
Week's Top 5 Gainers
Symbol 12/30 1/13 % change
BDSI 0.81 2.08 158.37%
DNDN 7.60 14.03 84.61%
ACHN 7.62 12.37 62.34%
TKMR 1.50 2.15 43.33%
REGN 55.43 78.92 42.38%
Week's Top 5 Losers
Symbol 12/30 1/13 % change
DRRX 1.18 0.77 -34.75%
TSRX 7.15 5.33 -25.45%
AVEO 17.20 14.83 -13.78%
ARNA 1.87 1.65 -11.76%
PPHM 1.03 0.91 -11.46% |
